Work with thought leaders and academic experts from Richard Stockton College of New Jersey

Researchers on NotedSource with connections to Richard Stockton College of New Jersey include Matthew Scarnati, Dr. Christina Jackson, and John Sokol.

Matthew Scarnati

Old Bridge, New Jersey, United States of America
Neuroscientist driving preclinical drug development programs to combat neurological disease.
Education

Rutgers University - Busch Campus

PhD, Cell Biology and Neuroscience / December, 2017

Piscataway, New Jersey, United States of America

UMDNJ-School of Osteopathic Medicine Department of Molecular Biology

PhD Student , Molecular Biology / May, 2013

Stratford, New Jersey, United States of America

Stockton University

BS Biochemistry and Molecular Biology, Biochemsitry and Molecular Biology / May, 2009

Galloway, New Jersey, United States of America
Research Expertise
Neuroscience
Stem Cell Biology
Electrophysiology
Disease Modeling
Neuropsychiatric Disorders
About
I am a seasoned and perseverent pre-clinical drug development neuroscientist with over 12 years of research experience covering NEUROSCIENCE, Biochemistry, Molecular and Cellular Biology, Synaptic Physiology and Stem Cell Biology. My "never give up" attitude and vast experience in many disciplines adopts me the ability to address scientific questions in creative and unique ways. I have experience in pre-clinical small molecule drug development to support chemistry SAR to identify lead therapeutic candidates for neurology related targets. Experience in design, optimization and execution of both cell based and biochemical assays. I can provide expertise in synaptic physiology, and neuropsychiatric disease modeling. I have comprehensively studied the biological basis of addiction utilizing human stem cell biology and cellular reprogramming techniques. I am well versed in cutting edge induced neuronal (iN) cell technology. My main roles at PTC as a preclinical drug development Neuroscientist: -Provide subject matter expertise and leadership in the expansion of neuroscience and neurological disease understanding -Design and execute high-throughput in-vitro cell-based assays to screen 100s of small molecules to assist in driving chemistry SAR -Validation of new drug targets accomplished through elegant experimental design (both cell-based and biochemical) -My main focus was elucidating the mechanism(s) of action of one of PTCs lead small molecule drug candidates for a rare neurological disorder -Comprehensively screened primary mouse neuronal cultures (as well as human cell lines) to identify disease specific biomarkers for pharmacodynamic studies -Mentored and trained associate level scientists on both the technical and conceptual framework of our teams small molecule pipeline -Translating in-vitro cell based findings into in-vivo rodent models to better understand the PK/PD relationship of our lead small molecule -Team lead for a gene-therapy focused project to combat a devastating rare pediatric indication ➢ Scientific communication is a great strength of mine. My experience has provided me with excellent presentation skills and the ability to convey my work to diverse audiences. https://www.ncbi.nlm.nih.gov/myncbi/matthew.scarnati.1/bibliography/public/ EMAIL: matthewscarnati@gmail.com SKILLS: Pre\-Clinical Drug Discovery I Electrophysiology \| Human Stem Cell Biology \| Mammalian Tissue Culture \| Cell Signaling Pathways \| Confocal Microscopy \| Protein Purification and Expression \| qPCR \| Cellular Assays \| Science Writing \| Problem Solving \| ELISA

See Full Profile

More Information About Richard Stockton College of New Jersey